Displaying drugs 101 - 125 of 7342 in total
Alfacalcidol
Alfacalcidol, or 1-alpha-hydroxycholecalciferol or 1-alpha-hydroxyvitamin D3, is a non-endogenous analogue of vitamin D. It plays an essential function in calcium homeostasis and bone metabolism. Alfacaldisol is activated by the enzyme 25-hydroxylase in the liver to mediate its effects in the body, or most importantly, the kidneys and bones. The pharmacological...
Approved
Nutraceutical
Matched Iupac: … (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-octahydro-1H-inden-4-ylidene] ... ethylidene}-4-methylidenecyclohexane-1,3-diol …
Pramipexole
Pramipexole is a drug used to treat the symptoms of Parkinson's Disease (PD). It is a non-ergot dopamine agonist drug that is efficacious in treating various Parkinson's symptoms such as tremor, rigidity, and bradykinesia (slow movement) . It was first approved by the FDA in 1997 . Parkinson's Disease is...
Approved
Investigational
Magnesium hydroxide
Magnesium hydroxide is an inorganic compound. It is naturally found as the mineral brucite. Magnesium hydroxide can be used as an antacid or a laxative in either an oral liquid suspension or chewable tablet form.
Additionally, magnesium hydroxide has smoke suppressing and flame retardant properties and is thus used commercially...
Approved
Investigational
Matched Mixtures name: … HIDROXDO DE ALUMINIO 4% + HIDROXDO DE MAGNESIO 4% + SIMETICONA 0.4% SUSPENSION ... HIDROXIDO DE ALUMINIO 4% + HIDROXIDO DE MAGNESIO 4% + SIMETICONA 0.4% SUSPENSION …
Matched Products: … Milk Of Magnesia 7% To 8.5% ... MAGCINE 5 GR 10 POSET ... MAGCINE 5 GR 20 POSET …
Matched Products: … Milk Of Magnesia 7% To 8.5% ... MAGCINE 5 GR 10 POSET ... MAGCINE 5 GR 20 POSET …
Doxercalciferol
Doxercalciferol is a synthetic vitamin D2 analog that undergoes metabolic activation in vivo to form 1α,25-dihydroxyvitamin D2 (1α,25-(OH)2D2), a naturally occurring, biologically active form of vitamin D2. Doxercalciferol is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment...
Approved
Matched Iupac: … -4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol ... (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden …
Matched Description: … dialysis, as well as for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 …
Matched Description: … dialysis, as well as for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 …
Taliglucerase alfa
Taliglucerase alfa is the recombinant active form of the human lysosomal enzyme, β-glucocerebrosidase. It was approved in 2012 and is marketed under the name Elelyso for use in patients with type 1 Gaucher's disease.
Approved
Investigational
Melphalan flufenamide
Melphalan flufenamide, also known as melflufen or J1, is a prodrug of melphalan.[A230123,L32173] Melphalan flufenamide is more readily uptaken by cells than melphalan, and is cleaved to the active metabolite by aminopeptidases. In vitro models show that melphalan is 10 to hundreds of times more potent than melphalan. The increased...
Approved
Withdrawn
Matched Iupac: … ethyl (2S)-2-[(2S)-2-amino-3-{4-[bis(2-chloroethyl)amino]phenyl}propanamido]-3-(4-fluorophenyl)propanoate …
Matched Description: … treatment option for patients with relapsed or refractory multiple myeloma who have attempted at least 4 …
Matched Salts cas: … 380449-54-7 …
Matched Description: … treatment option for patients with relapsed or refractory multiple myeloma who have attempted at least 4 …
Matched Salts cas: … 380449-54-7 …
Minoxidil
A potent direct-acting peripheral vasodilator (vasodilator agents) that reduces peripheral resistance and produces a fall in blood pressure.
Approved
Investigational
Matched Iupac: … 2,6-diamino-4-(piperidin-1-yl)pyrimidin-1-ium-1-olate …
Matched Salts cas: … 210357-39-4 …
Matched Mixtures name: … MINOXIDIL 7% / NIACINAMIDE 4% s ... Bakumokon 5% Minoxidil ... Minoxidil 7% / Progesterone 0.1% …
Matched Products: … VELLO-5 TOPICAL SOLUTION 5% W/V ... โมซาดิล-5 ... 5% Minoxidil …
Matched Salts cas: … 210357-39-4 …
Matched Mixtures name: … MINOXIDIL 7% / NIACINAMIDE 4% s ... Bakumokon 5% Minoxidil ... Minoxidil 7% / Progesterone 0.1% …
Matched Products: … VELLO-5 TOPICAL SOLUTION 5% W/V ... โมซาดิล-5 ... 5% Minoxidil …
Methoxy polyethylene glycol-epoetin beta
Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than erythropoietin. ESA is used to increase synthesis of red blood cells to treat chronic kidney disease associated anemia.
Approved
Gadobutrol
Gadobutrol is a second-generation extracellular non-ionic macrocyclic GBCA (gadolinium-based contrast agent) used in magnetic resonance imaging (MRI) in adults and children older than 2 years of age. Due to its physicochemical properties, gadobutrol is
formulated at twice the gadolinium ion concentration compared to other GBCA and thus requires a lesser...
Approved
Plecanatide
Plecanatide is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC). It should not be used in children less than six years of age, and should be avoided in patients six years to 18 years of age
Approved
Investigational
Matched Iupac: … (4S)-4-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-carboxy-1-hydroxypropylidene ... 3,6,9,12,15,18,21,24,30,33,36-undecahydroxy-10-[(C-hydroxycarbonimidoyl)methyl]-32-[(1R)-1-hydroxyethyl]-4- ... ]amino}-4-{[(1R,4S,7S,10S,13S,16R,19S,22S,25R,32S,38R)-38-{[(1S)-1-carboxy-3-methylbutyl]-C-hydroxycarbonimidoyl …
Paromomycin
An oligosaccharide antibiotic produced by various streptomyces. [PubChem]
Approved
Investigational
Matched Iupac: … (2R,3S,4R,5R,6S)-5-amino-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-4-{[(2R,3R,4R,5S,6S)-3-amino ... -6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl …
Matched Salts cas: … 1263-89-4 …
Matched Salts cas: … 1263-89-4 …
Ribostamycin
Ribostamycin is an aminoglycoside antibiotic isolated from Streptomyces ribosidificus listed as one of the World Health Organization's critically important antimicrobials.
Approved
Experimental
Matched Iupac: … -5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol ... (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-3,4-dihydroxy …
Ubrogepant
Ubrogepant is indicated for the acute treatment of migraine headaches with or without aura in adults. It was approved by the FDA on December 23, 2019, and is the first oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for the acute treatment of migraine. Several oral small molecule CGRP receptor...
Approved
Investigational
Matched Iupac: … (6S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2'-oxo-1',2',5,7-tetrahydrospiro …
Memantine
Initially approved by the FDA in 2013, memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist used in the management of Alzheimer's Disease (AD). It is different from many other Alzheimer's Disease medications, as it works by a different mechanism than the cholinesterase enzyme inhibitors normally employed in the management of Alzheimer's...
Approved
Investigational
Matched Synonyms: … 1,3-Dimethyl-5-adamantanamine …
Matched Mixtures name: … EMAXIN BASLANGIC SETI, 7+7+7+7 ADET ... EMAXIN BASLANGIC SETI, 7+7+7+7 ADET ... EMAXIN BASLANGIC SETI, 7+7+7+7 ADET …
Matched Products: … ZEIMER 5 MG / ML ... MEMANTIN-HCL NEURAX 5 MG ... MEMOLAN INIT 5/10/15/20MG …
Matched Mixtures name: … EMAXIN BASLANGIC SETI, 7+7+7+7 ADET ... EMAXIN BASLANGIC SETI, 7+7+7+7 ADET ... EMAXIN BASLANGIC SETI, 7+7+7+7 ADET …
Matched Products: … ZEIMER 5 MG / ML ... MEMANTIN-HCL NEURAX 5 MG ... MEMOLAN INIT 5/10/15/20MG …
Lanthanum carbonate
Lanthanum carbonate is a phosphate binder marketed under the trade name Fosrenol by Shire Pharmaceuticals. It is a large pill that requires thorough chewing to avoid choking and other gastrointestinal adverse effects. It is used to treat elevated phosphate levels, primarily in patients with chronic kidney disease, by binding to...
Approved
Saxagliptin
Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.
Approved
Matched Description: … (DPP-4) inhibitor class of drugs. ... Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 …
Matched Salts cas: … 709031-78-7 …
Matched Mixtures name: … Kombiglyze XR Tablet 5/500mg ... KOMBIGLYZE ® XR 5 MG/ 1000 MG ... Kombiglyze XR Tablet 5/1000mg …
Matched Products: … Onglyza Tablets 5 mg ... อองไกลซา (ชนิดเม็ด 5 มก.) ... ONGLYZA® 5 MG TABLETAS RECUBIERTAS. …
Matched Salts cas: … 709031-78-7 …
Matched Mixtures name: … Kombiglyze XR Tablet 5/500mg ... KOMBIGLYZE ® XR 5 MG/ 1000 MG ... Kombiglyze XR Tablet 5/1000mg …
Matched Products: … Onglyza Tablets 5 mg ... อองไกลซา (ชนิดเม็ด 5 มก.) ... ONGLYZA® 5 MG TABLETAS RECUBIERTAS. …
Hydroxyzine
Hydroxyzine is a first-generation histamine H1-receptor antagonist of the dephenylmethane and piperazine classes that exhibits sedative, anxiolytic, and antiemetic properties.[A1257,A187589] It was first developed in 1955, and has since remained a relatively common treatment for allergic conditions such as pruritus, urticaria, dermatoses, and histamine-mediated pruritus. The active metabolite of hydroxyzine,...
Approved
Matched Iupac: … 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethan-1-ol …
Matched Products: … ATARAX SYRUP 10 mg/5 ml ... HIZIN LIQUID 10 mg/5 ml ... HISTADREX JARABE 12.5 MG / 5 ML …
Matched Products: … ATARAX SYRUP 10 mg/5 ml ... HIZIN LIQUID 10 mg/5 ml ... HISTADREX JARABE 12.5 MG / 5 ML …
Calcipotriol
Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.
Approved
Matched Iupac: … -1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol ... (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-octahydro …
Matched Salts cas: … 147657-22-5 …
Matched Mixtures name: … Calcipotriene 0.005% / Niacinamide 4% …
Matched Salts cas: … 147657-22-5 …
Matched Mixtures name: … Calcipotriene 0.005% / Niacinamide 4% …
Oxolamine
Oxolamine is not approved in the USA, it may be marketed elsewhere internationally as a cough suppressant . It is listed as a prescription drug in New Zealand legislation . Oxolamine is also approved in Taiwan for the treatment of respiratory tract inflamation .
Approved
Matched Iupac: … diethyl[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]amine …
Matched Salts cas: … 131378-45-5 …
Matched Mixtures name: … KATARIN FORT 650 MG/200 MG/60 MG/4 MG FİLM KAPLI TABLET, 20 ADET ... ASE-COLD 120 mg+50mg+1mg/5 ml PEDİATRİK ŞURUP ... KATARIN 120 MG+50 MG+1 MG/5 ML PEDIATRIK SURUP 100 ML …
Matched Products: … OXOTUSS ŞURUP 50 MG/5 ML, 120 ML ... FENKO 62,4 MG/5 ML SURUP, 125 ML ... PEREBRON 50MG/5 ML 120 ML SURUP …
Matched Salts cas: … 131378-45-5 …
Matched Mixtures name: … KATARIN FORT 650 MG/200 MG/60 MG/4 MG FİLM KAPLI TABLET, 20 ADET ... ASE-COLD 120 mg+50mg+1mg/5 ml PEDİATRİK ŞURUP ... KATARIN 120 MG+50 MG+1 MG/5 ML PEDIATRIK SURUP 100 ML …
Matched Products: … OXOTUSS ŞURUP 50 MG/5 ML, 120 ML ... FENKO 62,4 MG/5 ML SURUP, 125 ML ... PEREBRON 50MG/5 ML 120 ML SURUP …
Oseltamivir
Oseltamivir (marketed as the product TamifluⓇ), is an antiviral neuraminidase inhibitor used for the treatment and prophylaxis of infection with influenza viruses A (including pandemic H1N1) and B. Oseltamivir exerts its antiviral activity by inhibiting the activity of the viral neuraminidase enzyme found on the surface of the virus, which...
Approved
Matched Synonyms: … Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate ... 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha …
Matched Iupac: … ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate …
Matched Description: … non-specific effects on symptoms (where the time to first alleviation of symptoms was only reduced from 7 …
Matched Products: … FLUHALT FOR ORAL SUSPENSION 60 mg/ 5 ml …
Matched Iupac: … ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate …
Matched Description: … non-specific effects on symptoms (where the time to first alleviation of symptoms was only reduced from 7 …
Matched Products: … FLUHALT FOR ORAL SUSPENSION 60 mg/ 5 ml …
Lasofoxifene
Lasofoxifene is a non-steroidal 3rd generation selective estrogen receptor modulator (SERM) that selectively binds to both ERα and ERβ with high affinity. It is a naphthalene derivative marketed for prevention and treatment of osteoporosis and for the treatment of vaginal atrophy. It was initially developed as Oporia by Pfizer as...
Approved
Investigational
Matched Synonyms: … (-)-cis-5,6,7,8-Tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol …
Matched Iupac: … (5R,6S)-6-phenyl-5-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-5,6,7,8-tetrahydronaphthalen-2-ol …
Matched Iupac: … (5R,6S)-6-phenyl-5-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-5,6,7,8-tetrahydronaphthalen-2-ol …
N-acetyltyrosine
N-acetyltyrosine, also referred to as N-acetyl-L-tyrosine, is used in place of as a tyrosine precursor. DB00135 is a non-essential amino acid with a polar side group. N-acetyltyrosine is administered as parenteral nutrition or intravenous infusion due to its enhanced solubility compared to tyrosine . It is typically administered as a...
Approved
Matched Synonyms: … (2s)-2-acetylamino-3-(4-hydroxyphenyl)propanoic acid ... (+)-(2s)-2-(acetylamino)-3-(4-hydroxyphenyl)propanoic acid …
Matched Iupac: … (2S)-2-acetamido-3-(4-hydroxyphenyl)propanoic acid …
Matched Mixtures name: … Aminosyn II 5% Inj ... AMINOPLASMAL-5% E INFUSION ... Aminosyn II 7% Injection …
Matched Iupac: … (2S)-2-acetamido-3-(4-hydroxyphenyl)propanoic acid …
Matched Mixtures name: … Aminosyn II 5% Inj ... AMINOPLASMAL-5% E INFUSION ... Aminosyn II 7% Injection …
Cisatracurium
Cisatracurium is a non-depolarising neuromuscular blocking agent of the benzylisoquinolinium class, available in its salt form, cisatracurium besylate.[A243416,A253592] Cisatracurium has an intermediate duration of action and is one of the most commonly used neuromuscular blocking agents in intensive care.[A253592,A253597]. Cisatracurium acts on cholinergic receptors, blocking neuromuscular transmission. This action is...
Approved
Investigational
Matched Iupac: … (1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-2-(3-{[5-({3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy …
Matched Products: … NİMBEX 10 MG/5 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... NİMBEX 5 MG/2.5 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... นิมเบ็กซ์ (ชนิดฉีด 5 มก./มล.) …
Matched Products: … NİMBEX 10 MG/5 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... NİMBEX 5 MG/2.5 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... นิมเบ็กซ์ (ชนิดฉีด 5 มก./มล.) …
Drospirenone
Drospirenone is a synthetic progestin commonly found in the popular oral contraceptive, Yaz in combination with Ethinyl estradiol. Most recently, it was approved by both Health Canada and the FDA in combination with Estetrol as an oral contraceptive therapy.[L33199,L33174] Aside from its contraceptive effects, drospirenone is used with estrogens to...
Approved
Matched Synonyms: … 6β,7β;15β,16β-Dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone …
Matched Iupac: … ene-5',7-dione ... )-10,14-dimethylspiro[hexacyclo[9.8.0.0^{2,4}.0^{5,10}.0^{14,19}.0^{16,18}]nonadecane-15,2'-oxolan]-5- …
Matched Mixtures name: … Drosfemine 0,02 mg/3 mg 24+4 Filmtabletten ... DROSPERA 3 MG/0.02 MG FILM KAPLI TABLET,24+4 ADET ... YAZZ 3 MG/0.02 MG FILM KAPLI TABLET, 3×(24+4) TABLET, 28 ADET …
Matched Products: … Lyzbet 4 mg Filmtabletten ... GYNETS® 4 MG TABLETAS RECUBIERTAS ... ZLYNDA 4 MG FİLM KAPLI TABLET, 28 ADET …
Matched Iupac: … ene-5',7-dione ... )-10,14-dimethylspiro[hexacyclo[9.8.0.0^{2,4}.0^{5,10}.0^{14,19}.0^{16,18}]nonadecane-15,2'-oxolan]-5- …
Matched Mixtures name: … Drosfemine 0,02 mg/3 mg 24+4 Filmtabletten ... DROSPERA 3 MG/0.02 MG FILM KAPLI TABLET,24+4 ADET ... YAZZ 3 MG/0.02 MG FILM KAPLI TABLET, 3×(24+4) TABLET, 28 ADET …
Matched Products: … Lyzbet 4 mg Filmtabletten ... GYNETS® 4 MG TABLETAS RECUBIERTAS ... ZLYNDA 4 MG FİLM KAPLI TABLET, 28 ADET …
Luspatercept
Luspatercept is a recombinant fusion protein comprised of a modified extracellular domain of activin receptor type IIB fused to the FC domain of human IgG1.[A187829,L42455] It was first approved for use in the United States in November 2019 under the brand name Reblozyl® for the treatment of anemia in patients...
Approved
Investigational
Displaying drugs 101 - 125 of 7342 in total